Show simple item record

Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation

dc.contributor.authorHoffman, S. A.en_US
dc.contributor.authorWang, L.en_US
dc.contributor.authorShah, Chirag V.en_US
dc.contributor.authorAhya, V. N.en_US
dc.contributor.authorPochettino, A.en_US
dc.contributor.authorOlthoff, Kim M.en_US
dc.contributor.authorShaked, Abrahamen_US
dc.contributor.authorWille, K.en_US
dc.contributor.authorLama, V. N.en_US
dc.contributor.authorMilstone, A.en_US
dc.contributor.authorWare, L. B.en_US
dc.contributor.authorOrens, J.en_US
dc.contributor.authorWeinacker, A.en_US
dc.contributor.authorDemissie, E.en_US
dc.contributor.authorBellamy, Scarletten_US
dc.contributor.authorKawut, S. M.en_US
dc.contributor.authorHancock, W. W.en_US
dc.contributor.authorChristie, Jason D.en_US
dc.date.accessioned2010-06-01T19:01:08Z
dc.date.available2010-06-01T19:01:08Z
dc.date.issued2009-02en_US
dc.identifier.citationHoffman, S. A.; Wang, L.; Shah, C. V.; Ahya, V. N.; Pochettino, A.; Olthoff, K.; Shaked, A.; Wille, K.; Lama, V. N.; Milstone, A.; Ware, L. B.; Orens, J.; Weinacker, A.; Demissie, E.; Bellamy, S.; Kawut, S. M.; Hancock, W. W.; Christie, J. D. (2009). "Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation." American Journal of Transplantation 9(2): 389-396. <http://hdl.handle.net/2027.42/72208>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72208
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19120076&dopt=citationen_US
dc.format.extent223225 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2009 American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.subject.otherChemokinesen_US
dc.subject.otherCytokinesen_US
dc.subject.otherLung Transplantationen_US
dc.subject.otherPrimary Graft Dysfunctionen_US
dc.subject.otherReperfusion Injuryen_US
dc.titlePlasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantationen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, PAen_US
dc.contributor.affiliationotherDivision of Transplantation Immunology, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PAen_US
dc.contributor.affiliationotherDepartment of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PAen_US
dc.contributor.affiliationotherDepartment of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PAen_US
dc.contributor.affiliationotherDivision of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, ALen_US
dc.contributor.affiliationotherDivision of Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, TNen_US
dc.contributor.affiliationotherDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University Hospital, Baltimore, MDen_US
dc.contributor.affiliationotherDivision of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CAen_US
dc.contributor.affiliationotherDivision of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NYen_US
dc.contributor.affiliationotherDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NYen_US
dc.identifier.pmid19120076en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72208/1/j.1600-6143.2008.02497.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2008.02497.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceChristie JD, Bavaria JE, Palevsky HI et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51 – 60.en_US
dc.identifier.citedreferenceKing RC, Binns OA, Rodriguez F et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000; 69: 1681 – 1685.en_US
dc.identifier.citedreferenceChristie JD, Kotloff RM, Pochettino A et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232 – 1241.en_US
dc.identifier.citedreferenceArcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999; 340: 1081 – 1091.en_US
dc.identifier.citedreferenceDe Perrot M, Sekine Y, Fischer S et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002; 165: 211 – 215.en_US
dc.identifier.citedreferenceChristie JD, Sager JS, Kimmel SE et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005; 127: 161 – 165.en_US
dc.identifier.citedreferenceArcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: Predictors and outcomes. J Heart Lung Transplant 2005; 24: 1483 – 1488.en_US
dc.identifier.citedreferenceChristie JD, Kotloff RM, Ahya VN et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312 – 1316.en_US
dc.identifier.citedreferenceChristie JD, Van Raemdonck D, de Perrot M et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: Introduction and methods. J Heart Lung Transplant 2005; 24: 1451 – 1453.en_US
dc.identifier.citedreferenceChristie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454 – 1459.en_US
dc.identifier.citedreferencede Perrot M, Bonser RS, Dark J et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: Donor-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1460 – 1467.en_US
dc.identifier.citedreferencede Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490 – 511.en_US
dc.identifier.citedreferenceBarr ML, Kawut SM, Whelan TP et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: Recipient-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1468 – 1482.en_US
dc.identifier.citedreferenceSerrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 1994; 58: 1158 – 1162.en_US
dc.identifier.citedreferenceNaidu BV, Farivar AS, Woolley SM, Grainger D, Verrier ED, Mulligan MS. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant 2004; 23: 128 – 134.en_US
dc.identifier.citedreferenceWacholder S. Design issues in case control studies. Stat Methods Med Res 1995; 4: 293 – 309.en_US
dc.identifier.citedreferenceChristie JD, Robinson N, Ware LB et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007; 175: 69 – 74.en_US
dc.identifier.citedreferenceCovarrubias M, Ware LB, Kawut SM et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573 – 2578.en_US
dc.identifier.citedreferenceFrangogiannis NG. The role of the chemokines in myocardial ischemia and reperfusion. Curr Vasc Pharmacol 2004; 2: 163 – 174.en_US
dc.identifier.citedreferenceTatapudi RR, Muthukumar T, Dadhania D et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004; 65: 2390 – 2397.en_US
dc.identifier.citedreferenceMelter M, Exeni A, Reinders ME et al. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001; 104: 2558 – 2564.en_US
dc.identifier.citedreferenceHancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001; 193: 975 – 980.en_US
dc.identifier.citedreferenceHancock WW, Lu B, Gao W et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000; 192: 1515 – 1520.en_US
dc.identifier.citedreferenceMathur A, Baz M, Staples ED et al. Cytokine profile after lung transplantation: Correlation with allograft injury. Ann Thorac Surg 2006; 81: 1844 – 1849; discussion 1849–1850.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.